Expression predictions inform molecular interpretation of Alzheimer's disease risk loci
- 1Korea Advanced Institute of Science and Technology
Abstract
Sequence models predict the molecular effects of genetic variation, yet their contribution to interpreting Alzheimers disease (AD) association signals remains uncertain. Here we analysed AlphaGenome Atlas predictions for 111,446 common variants across 75 regions from a European-ancestry genome-wide association study (GWAS) of AD and related dementias. Predicted expression effects modestly tracked association within loci (mean partial Spearman {rho} = 0.018, P = 0.003) and were higher in variants with the highest posterior inclusion probability than in correlated variants outside credible sets (mean difference, 0.044 percentile units; P = 0.005). This relationship remained after adjustment for genic position ({rho} = 0.011, P = 0.026). Predicted splicing effects also tracked association, but this relationship was attenuated after the adjustment. Expression and splicing scores were associated with the corresponding Genotype-Tissue Expression (GTEx) quantitative trait locus (QTL) status, although these analyses did not establish colocalization or agreement in allelic direction. Across 50 loci with multiple fine-mapping candidates, predicted cellular labels were no more concentrated than in position-matched comparisons, and expression direction profiles showed no detectable excess concordance with lead variants. These findings support expression predictions as complementary evidence for interpreting AD risk variants, while showing that the assignment of cellular context must account for fine-mapping uncertainty.
Related
- TSC1-mTORC1 signaling in Alzheimer’s disease: an integrated bioinformatic analysis linking gene expression to neuropathology
- Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectives
- DNA-Encoded Library-Guided Discovery of a First-in-Class Molecular Glue of the NOS1AP-SCRIB Complex in Alzheimer's Disease Patient-Derived Neurons
- Too early for LATE? Age at onset is associated with the clinical and neuroimaging expression of limbic-predominant age-related TDP-43 pathology in Alzheimer's disease
- Alzheimer’s disease research must connect vascular molecular phenotypes with physiology
BibTeX
@misc{hyug2026expression,
title = {{Expression predictions inform molecular interpretation of Alzheimer's disease risk loci}},
author = {C. byung hyug and J. Jeong},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.07.26364928},
url = {https://www.medrxiv.org/content/10.64898/2026.10.07.26364928v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Expression predictions inform molecular interpretation of Alzheimer's disease risk loci
AU - C. byung hyug
AU - J. Jeong
PY - 2026
DA - 2026/10/07
PB - medRxiv
DO - 10.64898/2026.10.07.26364928
UR - https://www.medrxiv.org/content/10.64898/2026.10.07.26364928v1
AB - Sequence models predict the molecular effects of genetic variation, yet their contribution to interpreting Alzheimers disease (AD) association signals remains uncertain. Here we analysed AlphaGenome Atlas predictions for 111,446 common variants across 75 regions from a European-ancestry genome-wide association study (GWAS) of AD and related dementias. Predicted expression effects modestly tracked association within loci (mean partial Spearman {rho} = 0.018, P = 0.003) and were higher in variants with the highest posterior inclusion probability than in correlated variants outside credible sets (mean difference, 0.044 percentile units; P = 0.005). This relationship remained after adjustment for genic position ({rho} = 0.011, P = 0.026). Predicted splicing effects also tracked association, but this relationship was attenuated after the adjustment. Expression and splicing scores were associated with the corresponding Genotype-Tissue Expression (GTEx) quantitative trait locus (QTL) status, although these analyses did not establish colocalization or agreement in allelic direction. Across 50 loci with multiple fine-mapping candidates, predicted cellular labels were no more concentrated than in position-matched comparisons, and expression direction profiles showed no detectable excess concordance with lead variants. These findings support expression predictions as complementary evidence for interpreting AD risk variants, while showing that the assignment of cellular context must account for fine-mapping uncertainty.
ER -